XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Nov. 01, 2020
Nov. 03, 2019
Cash flows from operating activities:    
Net earnings $ 371,759 $ 190,017
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 140,340 140,495
(Gain) loss on disposal/impairment of assets 26,220 682
Amortization of deferred lease incentives (4,538) (5,985)
Non-cash lease expense 162,767 160,138
Deferred income taxes (6,969) (10,937)
Tax benefit related to stock-based awards 13,143 13,648
Stock-based compensation expense 54,671 49,516
Other (9) 14
Changes in:    
Accounts receivable (18,017) (2,842)
Merchandise inventories (22,990) (133,637)
Prepaid expenses and other assets (4,807) (24,157)
Accounts payable 54,279 (92,101)
Accrued expenses and other liabilities 58,539 (24,148)
Gift card and other deferred revenue 59,953 5,848
Operating lease liabilities (171,245) (168,308)
Income taxes payable 13,532 (8,293)
Net cash provided by operating activities 726,628 89,950
Cash flows from investing activities:    
Purchases of property and equipment (124,885) (121,154)
Other 506 470
Net cash used in investing activities (124,379) (120,684)
Cash flows from financing activities:    
Borrowings under revolving line of credit 487,823 100,000
Repayments under the revolving line of credit (487,823)  
Payment of dividends (116,761) (113,159)
Repurchases of common stock (109,048) (112,714)
Tax withholdings related to stock-based awards (30,555) (26,623)
Debt issuance costs (3,645)  
Net cash used in financing activities (260,009) (152,496)
Effect of exchange rates on cash and cash equivalents (1,232) (699)
Net increase (decrease) in cash and cash equivalents 341,008 (183,929)
Cash and cash equivalents at beginning of period 432,162 338,954
Cash and cash equivalents at end of period $ 773,170 $ 155,025